Cargando…

Impact of COVID-19 on Pediatric Immunocompromised Patients

.

Detalles Bibliográficos
Autores principales:	Connelly, James A., Chong, Hey, Esbenshade, Adam J., Frame, David, Failing, Christopher, Secord, Elizabeth, Walkovich, Kelly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149202/ https://www.ncbi.nlm.nih.gov/pubmed/34538297 http://dx.doi.org/10.1016/j.pcl.2021.05.007

Ejemplares similares

MON-155 A Patient with Acquired Generalized Lipodystrophy (AGL, Lawrence Syndrome) in Association with CTLA-4 Haploinsufficiency
por: Ozer, Muhammet, et al.
Publicado: (2019)

Serum lactate is associated with increased illness severity in immunocompromised pediatric hematology oncology patients presenting to the emergency department with fever
por: Slatnick, Leonora Rose, et al.
Publicado: (2022)

Case Report: Use of Obinutuzumab as an Alternative Monoclonal Anti-CD20 Antibody in a Patient With Refractory Immune Thrombocytopenia Complicated by Rituximab-Induced Serum Sickness and Anti-Rituximab Antibodies
por: Blase, Jennifer R., et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Pediatric Bicycle Injury
por: Failing, Gates R. L., et al.
Publicado: (2023)

The Impact of Coronavirus Disease 2019 on Pediatric Asthma in the United States
por: Navalpakam, Aishwarya, et al.
Publicado: (2021)

Editorial: Women in pediatric immunology: 2021
por: Secord, Elizabeth
Publicado: (2022)

Outcome for immunocompromised pediatric critical patients
por: Peña, Y, et al.
Publicado: (2008)

Pseudofungi in an Immunocompromised Patient with Breast Cancer and COVID-19
por: Bilani, Nadeem, et al.
Publicado: (2020)

The Effect of COVID-19 on Education
por: Hoofman, Jacob, et al.
Publicado: (2021)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009
por: Mueller, Emily L., et al.
Publicado: (2015)

Covid-19 in Children
por: Secord, Elizabeth, et al.
Publicado: (2021)

Correction to: Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009
por: Mueller, Emily L., et al.
Publicado: (2017)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

COVID-19 in immunocompromised children and adolescents
por: Kwak, Byung Ok, et al.
Publicado: (2023)

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts
por: Davis, Amy, et al.
Publicado: (2020)

1074 Immunization Practices of Pediatric Oncology Providers Towards Children with Acute Lymphoblastic Leukemia that have Completed Chemotherapy
por: Sulieman, Salwa, et al.
Publicado: (2014)

Septic arthritis by Sphingobacterium multivorum in immunocompromised pediatric patient
por: Mendes, Maiana Darwich, et al.
Publicado: (2016)

SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition
por: Michniacki, Thomas F., et al.
Publicado: (2022)

Duration of isolation and precautions in immunocompromised patients with COVID-19
por: Taramasso, L., et al.
Publicado: (2021)

COVID-19 vaccines for high risk and immunocompromised patients
por: Pavia, Charles S., et al.
Publicado: (2022)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
por: Song, Jin-Wen, et al.
Publicado: (2022)

The unmet need for COVID-19 treatment in immunocompromised patients
por: Alessandra, D’Abramo, et al.
Publicado: (2022)

HMPV in Immunocompromised Patients: Frequency and Severity in Pediatric Oncology Patients
por: Martinez-Rodriguez, Cesar, et al.
Publicado: (2020)

Absolute neutrophil count nadir in healthy pediatric patients with the Duffy-null phenotype
por: Merz, Lauren E., et al.
Publicado: (2023)

The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era
por: Calabrese, Leonard H., et al.
Publicado: (2022)

Cutaneous Leishmaniasis in an Immunocompromised Pediatric Patient With Acute Lymphoblastic Leukemia
por: Cohen, Stephanie R, et al.
Publicado: (2021)

The impact of immunocompromise on outcomes of COVID-19 in children and young people—a systematic review and meta-analysis
por: Greenan-Barrett, James, et al.
Publicado: (2023)

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
por: Lee, Ainsley Ryan Yan Bin, et al.
Publicado: (2022)

How Do We Take Care of Children During this COVID-19 Pandemic?
por: Secord, Elizabeth, et al.
Publicado: (2021)

A Short Series of Case Reports of COVID-19 in Immunocompromised Patients
por: Mishra, Mitali, et al.
Publicado: (2022)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

Correction: The unmet need for COVID-19 treatment in immunocompromised patients
por: D’Abramo, Alessandra, et al.
Publicado: (2023)

Foreword: Preventing COVID-19 Among the Immunocompromised Population
por: Willicombe, Michelle
Publicado: (2023)

Making the Middle Count: Three Tools to Improve Throughput for a Better Patient Experience
por: Esbenshade, Angie
Publicado: (2015)

Antibacterial honey (Medihoney(®)) for wound care of immunocompromised pediatric oncology patients
por: Simon, Arne, et al.
Publicado: (2006)

Immunocompromised pediatric patients with acute respiratory failure: outcome and prognosis factors
por: Pujol, M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_b729r902vuga6hb9vhv7lbisq1